Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06850870 · ClinicalTrials.gov registry record · Phase 1
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
A Phase 1 study of Dementia and Cognitive Decline, sponsored by Onward Health.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06850870 is a Phase 1 study of Dementia and Cognitive Decline that is actively recruiting participants, run by Onward Health. The registered enrollment target is 120 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06850870, a Phase 1 study of Dementia and Cognitive Decline, is actively recruiting participants, sponsored by Onward Health.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is: Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?
Conditions Studied
Interventions
- OTHER Door-through-door companion rideshare
- OTHER Curb-to-curb rideshare services
Study Locations (1)
California
- Onward Health HQ - San Leandro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-29 |
| Est. Completion | 2026-11-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06850870
The ClinicalTrials.gov registry entry for NCT06850870 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The listed sponsor is Onward Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Door-through-door companion rideshare is the first listed.
NCT06850870 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06850870 about?
NCT06850870 is a clinical study titled "Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)". The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-cu...
What is the current status of trial NCT06850870?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2025-08-29. Estimated completion is 2026-11-28.
What conditions does trial NCT06850870 study?
This clinical trial studies the following conditions: Dementia, Cognitive Decline, Alzheimer Disease or Associated Disorder.
What interventions are being tested in trial NCT06850870?
The interventions under investigation include: Door-through-door companion rideshare (OTHER), Curb-to-curb rideshare services (OTHER).
Who is sponsoring clinical trial NCT06850870?
This trial is sponsored by Onward Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06850870 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RECRUITING · Phase 1
-
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
RECRUITING · Phase 1
-
Sirtuin-NAD Activator in Alzheimer's Disease
ACTIVE NOT RECRUITING · Phase 1
-
Home Safety Clinical Trial for Alzheimer's Disease
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.